IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

Item
http://www.wikidata.org/entity/Q34687192
Interleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosusTh1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic painInteractions between the immune and nervous systems in pain.Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO-cGMP-PKG-KATP Channel Signaling PathwayIL-33 mediates antigen-induced cutaneous and articular hypernociception in miceIL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2Endothelin receptors and painPeripheral mechanisms of pain and analgesia.Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision.Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1.Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats.Tephrosia sinapou ethyl acetate extract inhibits inflammatory pain in mice: opioid receptor dependent inhibition of TNFα and IL-1β production.Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice.IL-15 and RANKL Play a Synergistically Important Role in Osteoclastogenesis.Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.
P2860

IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

Item
http://www.wikidata.org/entity/Q34687192
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@ast
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@en
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@nl
type
label
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@ast
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@en
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@nl
prefLabel
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@ast
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@en
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
IL-15 mediates immune inflamma ...... endothelin, and prostaglandin.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932